Patna, Bihar
GST No. 10ABIFR4965L1ZV
Call 08047309873 60% Response Rate
Send Enquiry
| Strength | 100mg |
| Packaging Size | 100mg |
| Packaging Type | Vial |
| Usage | Clinical |
| Shelf Life | Mention in Box |
Trastuzumab deruxtecan is indicated for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting and for adults
View Complete details